This trial will test if a new drug is safe and effective for treating acute gout flare-ups.
- Gout Flare
- Gout Attack
1 Primary · 11 Secondary · Reporting Duration: 12, 24, 36, 48 and 60 hours; 8 and 15 days
2 Treatment Groups
1 of 2
1 of 2
300 Total Participants · 2 Treatment Groups
Primary Treatment: Dapansutrile · Has Placebo Group · Phase 2 & 3
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the enrollment size of this investigation?
"Affirmative, the clinicaltrials.gov database reveals that this medical study is still enrolling participants. Initially posted on 6th January 2022 and last updated 9th July 2023, 300 patients are needed to be recruited from one centre alone." - Anonymous Online Contributor
Is there still opportunity for enrollment in this experiment?
"Yes, the published details on clinicaltrials.gov suggest that this trial is in progress and actively seeking participants. The study was originally posted on June 1st 2022 and amended most recently on September 1st 2023; it desires to recruit 300 patients from a single medical centre." - Anonymous Online Contributor